LANSOPRAZOLE

Sterling Knight Pharmaceuticals LLC🇺🇸 United States

FDA Page

Effective Date: Oct 31, 2016
Approval ID: 1cf560fe-df28-44df-8e33-30409f33f2ef
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use lansoprazole delayed-release capsules, USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules. LANSOPRAZOLE DELAYED-RELEASE CAPSULES USP, for oral useInitial U.S. Approval : 1995

Quick Stats

Total Products1

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.